Improved outcome following allogeneic stem cell transplantation in chronic myeloid leukemia is associated with higher expression of BMI-1 and immune responses to BMI-1 protein

Podobne zapisy

• Ex vivo characterization of polyclonal memory CD8(+) T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia
  od: Rezvani, Katayoun, i wsp.
  Wydane: (2009)
• Hematopoietic stem cells and progenitors of chronic myeloid leukemia express leukemia-associated antigens: implications for the graft-versus-leukemia effect and peptide vaccine-based immunotherapy
  od: Yong, Agnes S. M., i wsp.
  Wydane: (2008)
• High PR3 or ELA2 expression by CD34(+) cells in advanced-phase chronic myeloid leukemia is associated with improved outcome following allogeneic stem cell transplantation and may improve PR1 peptide–driven graft-versus-leukemia effects
  od: Yong, Agnes S. M., i wsp.
  Wydane: (2007)
• Repeated PR1 and WT1 peptide vaccination in Montanide-adjuvant fails to induce sustained high-avidity, epitope-specific CD8(+) T cells in myeloid malignancies
  od: Rezvani, Katayoun, i wsp.
  Wydane: (2011)
• Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapy
  od: Rezvani, Katayoun, i wsp.
  Wydane: (2011)